Berberine is a type of bioactive compound that belongs to
the class of alkaloids, and is widely used after extracting it from a
group of shrubs called Berberis. It is yellow in color and has been
also used in the form of a dye. In traditional Chinese medicine,
the use of berberine has a long history to treat various ailments
[1]. It can be obtained from the rhizomes, roots, bark, and stem of
the Berberis plants. Several studies reported the use of berberine
extracts and decoctions due to its antimicrobial activity against
bacteria, fungi, viruses, protozoans, Chlamydia, and helminths
[2,3]. Moreover, there were various preclinical and clinical
studies that explained the ameliorative effect of berberine against
various neurological, metabolic, and cardiological problems [4]. Besides, it also showed its pharmacological use when applied
as a gel by reducing the redness, pain, oozing, and ulcer sizes in
canker sores patients. It is also recommended to slightly reduce
the blood sugar levels in diabetic patients and might control
the level of sugar in the body as effectively as rosiglitazone or
metformin [5,6]. Some scientific studies also indicated the use
of berberine in lowering the cholesterol levels in patients as it
seems to reduce the total cholesterol, low-density lipoprotein, as
well as the triglyceride levels in the body [7]. Its use has also been
evident in lowering the blood pressure when used with the drug
amlodipine as it reduces the systolic and diastolic blood pressure
more effectively as compared to taking amlodipine alone in
patients [8]. Moreover, some researches also suggest that it’s used
in women with PCOS that may help in lowering the blood sugar,
reducing the testosterone levels, improving the cholesterol and
triglyceride levels, and thereby also lower the waist-to-hip ratio
[9]. Besides, there are several other health benefits of berberine
that includes fight against depression [10], reduce the growth
and spread of various types of cancer [11], potent antioxidant
and anti-inflammatory effects [12], prevent infections by fighting
with harmful microorganisms, such as viruses, bacteria, fungi
and different parasites [13], reduce fat build-up in the liver, and
thereby prevent the non-alcoholic fatty liver disease (NAFLD)
[14], improved the symptoms and reduced the risk of death in
heart failure patients [15], etc. Despite such wide uses, it was
reported that the absorption of berberine across the gut wall
was poor and it got easily metabolized in the liver and further
get excreted with the bile [16,17]. Thus, the research studies
should be done with an emphasis on enhancing the berberine bioavailability that could be done by altering its physicochemical properties [18].
Biofield Energy Healing Treatment is known these days for
altering the various properties of a drug that might affect its
bioavailability. Energy healing is a kind of Complementary and
Alternative Medicine (CAM) that was performed with significant
clinical and non-clinical outcomes and accepted worldwide
[19,20]. There are various Energy Healing Therapies such as,
Reiki, yoga, therapeutic touch, pranic healing, deep breathing,
pilates, Ayurvedic medicine, traditional Chinese herbs and
medicines, homeopathy, hypnotherapy, and acupressure,
etc. that have been accepted by the National Center for
Complementary and Alternative Medicine (NCCAM) [21,22]. The
Trivedi Effect®-Consciousness Energy Healing therapies is also
such type of CAM therapies that have been reported by various
researchers for its significant impact in the non-living materials
and living organisms. The effect of Consciousness Energy
Healing Treatment has been found in improving the crop yield in
agriculture science [23,24], nutraceuticals properties [25,26], the
physicochemical properties of metals and ceramics [27-29], skin
health [30,31], bioavailability of various drugs [32-34], and in the
field of microbiology [35-37], biotechnology [38, 39], bone health
[40-42], cancer science research [43,44], and human health and
wellness. This study was aimed to understand and estimate
the effect of Biofield Energy Treatment on the physicochemical
properties of berberine by using various modern analytical
techniques.
Chemicals and reagents
The test sample berberine chloride was procured from Tokyo
Chemical Industry Co., Ltd., Japan and other chemicals used in the
research work were purchased in India.
Consciousness energy healing treatment strategies
The test sample berberine was divided into two equal parts.
One part of the test sample was considered as a control sample,
which did not receive the Biofield Energy Treatment. But, the
control sample was treated with an ignorant person who did
not have any knowledge about the Biofield Energy Treatment
is called the “sham” healer. However, the second part of the
test sample has received the Energy of Consciousness Healing
Treatment (Trivedi Effect®) remotely for 3 minutes and known
as the treated berberine sample. This Biofield Energy Treatment
was provided through the healer’s unique energy transmission
process by the renowned Biofield Energy Healer, Dahryn Trivedi,
USA. After the treatment, both the samples were stored in sealed
conditions and characterized using modern analytical techniques.
Characterization
The powder X-ray diffraction (PXRD) analysis of berberine
chloride powder sample was executed with the help of Rigaku
MiniFlex-II Desktop X-ray diffractometer (Japan) [45,46]. The
average crystallites size was calculated using the Scherrer’s formula (1)
G = kλ/βcosθ (1)
Where k is the equipment constant, G is the crystallite size
in nm, β is the full-width at half maximum, λ is the radiation
wavelength, and θ is the Bragg angle [47].
The particle size analysis (PSA) was performed on Malvern
Master sizer 2000, from the UK using the wet method [48].
Similarly, the DSC analysis of berberine chloride was performed
with the help of DSC Q200, TA instruments. The thermal
gravimetric analysis/ differential thermogravimetric analysis
(TGA/DTG) thermograms of berberine chloride were obtained
with the help of TGA Q50 TA instruments [49].
The % change in specific surface area, particle size, peak
intensity, melting point, latent heat, crystallite size, weight
loss and Tmax of the treated berberine chloride was calculated
compared to the control sample using the following equation 2:
(2)
${\rm{\% change}} = {{\left[ {{\rm{Treated}} - {\rm{Control}}} \right]} \over {{\rm{Control}}}} \times 100$
Powder X-ray diffraction (PXRD) analysis
The PXRD analysis showed the diffractograms of the control
and treated berberine that involve the details of the Bragg’s
angles of the characteristic peaks in both the samples (Figure
1). The diffractograms were further analysed with respect
to the relative intensities of the characteristic peaks and the
corresponding crystallite sizes of both the samples and the
details were mentioned in Table 1.
The analysis of the diffractograms indicated that the Bragg’s
angles (2θ) of the characteristic peaks of the treated berberine
chloride sample were slightly altered in comparison to the 2θ
of the peaks of the control sample. However, the major changes
were observed in the relative intensities of the peaks of the
treated berberine as well as the corresponding crystallite sizes,
when compared with the control sample. The peak intensities
of the treated berberine were mostly increased in the range
from 2.72% to 309.30% except the peak at 25.62º that showed
reduced intensity by 7.30%, compared to the control sample.
Similarly, the crystallite sizes of the treated berberine were
significantly altered in the range from -73.02% to 72.04%,
compared to the control sample. Moreover, the treated berberine
showed a significant reduction in the average crystallite size
that was decreased from 245.30 nm (control) to 216.20 nm,
i.e., 11.86% than the control sample. The new polymorph
formation might take place after the Biofield Energy Treatment
of the compounds as reported earlier in various research studies
[48,49]. Such changes could be attributed to the alterations in the
peak intensities of the characteristic peaks of the diffractogram
and their corresponding crystallite sizes after the Biofield
Energy Treatment of the compounds and thereby the changes
in their crystalline properties [50]. Hence, the novel polymorph
of berberine chloride might form after the treatment of the
berberine chloride that might show some altered crystal habit
than the control berberine; and could be used as an approach for
the improvement of the solubility and bioavailability profile [51].
Particle size analysis (PSA)
The particle size analysis of the samples indicate the changes
that might occur in the particle size distribution of the treated
berberine corresponding to d10, d50, d90, and D (4,3) after the
Biofield Energy Treatment, compared to the control sample
and the results are given in Table 2. It was observed that the
treated berberine showed a significant reduction in the particle
size distribution by 6.14% (d10), 11.22% (d50), 15.63% (d90), and
12.40% { D (4, 3)} than the control sample.
The significant changes in the particle sizes ultimately
contributed to the considerable increase in the specific surface
area of the treated berberine by 5.26% after the Biofield Energy
Treatment in comparison to the control sample. Several studies
have been done on establishing the relationship betweendrug
performance and its particle size distribution such as dissolution,
absorption, and bioavailability [52,53]. The approach of reducing
the particle size of the compound has been used by various
researchers to improve the effective surface area and thereby
the dissolution that ultimately increases the bioavailability of
compound [54]. Thus, it is presumed that the Biofield Energy
Treated berberine chloride might show improved bioavailability
and drug performance as it showed improved surface area than
the control sample.
Thermal Gravimetric Analysis (TGA)/ Differential Thermogravimetric Analysis (DTG)
The TGA/DTG data reported the thermal degradation pattern
of the treated berberine with respect to the control sample and
the differences regarding the weight loss, residue weight, and
maximum degradation temperature (Tmax) among the control
and treated berberine were reported in Table 3. There was
various scientific evidence on the thermal studies of berberine
chloride that reported its stability up to 350 K. Besides, the
TGA curve reported in those studies showed degradation of
berberine chloride in four-steps in between the temperature
range of 350 K to 520 K [55]. The TGA studies of the control and
the treated samples reported similar thermograms (Figure 2),
and further data regarding the weight loss and residue weight
were mentioned in Table 3. It was observed that the total
weight loss of the treated berberine chloride sample during the
thermal degradation was 50.27% that was significantly reduced
by 23.71%, compared to the weight loss of the control sample
(65.89%). Moreover, the significant reduction in the weight loss
during degradation resulted in 45.79% increase in the residue
weight, compared to the control sample (Table 3).
The previous DTG studies on the berberine chloride showed
that the DTG thermogram involves four peaks, which indicated
the various thermal decomposition products such as, H2O (379K),
CO (421K), CO (490K), and H2O (514K) [55]. This DTG study on
the control and treated berberine also reported the presence of four peaks in their respective DTG thermograms (Figure 3),
and the peak temperatures were found similar as mentioned in
the literature. The further analysis showed that the maximum
thermal degradation temperature (Tmax) of the treated berberine
corresponding to the 1st peak was decreased by 5.94%; while the other peaks such as 2nd, 3rd, and 4th peak were increased by
1.20%, 1.13%, and 1.70%, respectively in comparison to the Tmax
of the control sample. Hence, it was observed from the overall
TGA/DTG studies that the thermal degradation of the treated
berberine was reduced after the Biofield Energy Treatment that
indicated the improved thermal stability of the sample, compared
to the control berberine.
Differential Scanning Calorimetry (DSC) Analysis
The melting and degradation pattern of the control and treated
berberine chloride samples were studied by using DSC analysis
[56]. There was the presence of six peaks in the thermograms
of both the samples, which involves five endothermic peaks
while one exothermic peak (Figure 4). The analysis of the peak
temperatures indicated that the temperature corresponding to
1st, 2nd, 3rd, 4th, 5th, and 6th peak of the treated berberine chloride
sample were significantly altered by -3.78%, -2.99%, 1.14%,
0.50%, -0.15%, and -0.53%, respectively as compared to the
control berberine (Table 4). Besides, the significant changes
were also observed in the latent heat of fusion (ΔH) of the treated
berberine corresponding to each peak, compared to the control
sample. The ΔH corresponding to 1st, 2nd, 3rd, 4th, 5th, and 6th peak
were significantly altered by -66.59%, 20.04%, 26.32%, -12.31%, -40.34%, and 44.22%, respectively, compared to the control sample.
The overall study showed that the melting temperature and the
corresponding ΔH of the Biofield Energy Treated berberinewere
considerably changed after the treatment as compared to the
control berberine chloride sample. Such changes in the melting
behavior might be attributed tosome significant alterations in
the crystallization structure of the treated berberine after the
Biofield Energy Treatment [56].
In this study, significant changes were observed in the
physicochemical and thermal properties of berberine chloride
after the treatment with the Trivedi Effect®-Consciousness
Energy Healing Treatment. The PXRD study indicated the
significant alterations in the peak intensities of the Biofield
Energy Treated berberine in the range of -7.30% to 309.30%;
while the crystallite sizes were altered in the range from
-73.02% to 72.04%, compared to the control sample. The treated
berberine also showed alteration in the average crystallite size
that was significantly decreased by 11.86% as compared to
the control sample. Such significant changes in the crystalline properties of the treated berberine might indicate the formation
of some new polymorph of berberine chloride after the Biofield
Energy Treatment in comparison to the control sample. The
particle sizes of the Biofield Energy Treated berberine were
observed to reduce by 6.14% (d10), 11.22% (d50), 15.63% (d90),
and 12.40% {D(4,3)}, which thereby attributed to 5.26% increase
in the specific surface area as compared to the control sample.
Such alterations in the particle sizes and effective surface area
of the treated berberine after the Biofield Energy Treatment
might improve the solubility, dissolution, and bioavailability in
comparison to the control sample. The total weight loss of the
Biofield Energy Treated berberine showed a significant reduction
by 23.71% and 45.79% increase in the residue weight than the
control sample. Hence, the treated berberine chloride showed
better thermal stability after the Biofield Energy Treatment
compared to the control sample. The treated berberine showed
alterations in the melting temperatures corresponding to 1st,
2nd, 3rd, 4th, 5th, and 6th peak by -3.78%, -2.99%, 1.14%, 0.50%,
-0.15%, and -0.53%, respectively; while the ΔH was altered by
-66.59%, 20.04%, 26.32%, -12.31%, -40.34%, and 44.22%,
respectively, compared to the control sample. Thus, the overall
study concluded the impact of the Trivedi Effect®-Consciousness
Energy Healing Treatment on the physicochemical and thermal
properties of the berberine chloride sample. It was assumed that
there might be a formation of a new polymorph of berberine
chloride after the Biofield Energy Treatment that may possess
better dissolution, absorption, and thermal stability than the
control sample. Hence, the Trivedi Effect® Treated berberine
chloride could be used in formulating new pharmaceutical/
nutraceutical products with better efficacy and performance
against the treatment and prevention of various diseases such
as polycystic ovary syndrome, high cholesterol, hypertension,
gastric ulcers, inflammation, hyperglycemia, congestive heart
failure, metabolic syndromes, arrhythmia, fatty liver diseases,
depression, and prevent infections by fighting with harmful
microorganisms, such as viruses, bacteria, fungi, etc.
The authors are grateful to Central Leather Research Institute,
SIPRA Lab. Ltd., Trivedi Science, Trivedi Global, Inc., Trivedi
Testimonials, and Trivedi Master Wellness for their assistance
and support during this work.